# Rotavirus Efficacy and Safety Trial (REST)(V260-006)

> **NCT00090233** · PHASE3 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 69274 (actual)

## Conditions studied

- Rotavirus Infections

## Interventions

- **BIOLOGICAL:** Rotateq™
- **BIOLOGICAL:** Comparator: Placebo

## Key facts

- **NCT ID:** NCT00090233
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-01
- **Primary completion:** 2004-10
- **Final completion:** 2004-10
- **Target enrollment:** 69274 (ACTUAL)
- **Last updated:** 2015-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00090233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00090233, "Rotavirus Efficacy and Safety Trial (REST)(V260-006)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00090233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*